ArticleCancer medicine2016

Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma.

Taku Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.